XICLAV 250/62.5 mg is a broad-spectrum antibiotic that combines Amoxicillin, a penicillin-type antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. This combination extends the antibacterial spectrum of amoxicillin to cover organisms that produce beta-lactamase, an enzyme that normally resists standard penicillins.